- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: (PARP) Inhibitors
Total 64228 results
-
AbbVie (prior sponsor, Abbott)Completed
-
Centre Georges Francois LeclercActive, not recruiting
-
Tianjin Medical University Cancer Institute and...Recruiting
-
Sidney Kimmel Comprehensive Cancer Center at Johns...AstraZeneca; The Marcus Foundation; McGuff Pharmaceuticals, Inc.RecruitingProstate Cancer | Castration-resistant Prostate CancerUnited States
-
Ronald BuckanovichGenentech, Inc.RecruitingPARP Inhibitor | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Hedgehog InhibitorUnited States
-
Centre de Recherche Médicale de LambarénéInstitute of Tropical Medicine, University of TuebingenNot yet recruitingSevere Malarial TreatmentGabon
-
University Hospital, CaenCompleted
-
Xiaoxiang ChenNot yet recruitingOvarian Cancer | HRD | PARP InhibitorChina
-
University of Michigan Rogel Cancer CenterPfizer; Acrotech Biopharma Inc.RecruitingMetastatic Breast Cancer | Metastatic Castration-resistant Prostate Cancer | Metastatic Ovarian CarcinomaUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.Terminated
-
Cancer Institute and Hospital, Chinese Academy...RecruitingSafety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer (RADIOCOM)Chemotherapeutic Toxicity | Radiotherapy; Complications | PARP Inhibitor | Immune Checkpoint Inhibitor | Trastuzumab | Breast Cancer, Familial Male | CDK4/6 Inhibitor | PertuzumabChina
-
Jennifer Lauren KamensGateway for Cancer ResearchRecruitingAcute Myeloid LeukemiaUnited States
-
Rhizen Pharmaceuticals SACompletedSolid Tumor | Metastatic Breast Cancer | Locally Advanced Breast Cancer | Extensive-stage Small-cell Lung Cancer | Platinum-Sensitive Fallopian Tube Carcinoma | Platinum-sensitive Ovarian Cancer | Platinum-Sensitive Peritoneal CancerCzechia, Poland
-
Washington University School of MedicineActive, not recruiting
-
University Hospital, CaenCompleted
-
Hoosier Cancer Research NetworkClovis Oncology, Inc.CompletedBreast CancerUnited States
-
Centre Francois BaclesseNational Cancer Institute, FranceRecruitingRadiotherapy | PARP Inhibitor | Malignant GliomasFrance
-
University of PennsylvaniaTerminatedBreast Cancer | Ovarian Cancer | Solid TumorUnited States
-
University of Alabama at BirminghamWithdrawnOvarian Cancer RecurrentUnited States
-
University of Texas Southwestern Medical CenterWithdrawn
-
Xiaoxiang ChenRecruitingOvarian Cancer | PARP Inhibitor | Clinical MarkerChina
-
Tesaro, Inc.WithdrawnLymphoma | Mantle-Cell
-
Zai Lab (Shanghai) Co., Ltd.Completed
-
Haider MahdiGlaxoSmithKline; Zenith EpigeneticsRecruitingOvarian Cancer | Recurrent Solid TumorsUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisMerck Sharp & Dohme LLCNot yet recruiting
-
Erasmus Medical CenterRecruitingNeuroendocrine Tumors | Peptide Receptor Radionuclide TherapyNetherlands
-
Paul Mathew, MDHoosier Cancer Research Network; Tesaro, Inc.TerminatedMetastatic Prostate CancerUnited States
-
Yonsei UniversityTakedaRecruitingPlatinum-sensitive Recurrent Ovarian Cancer Patients Previously Treated With a PARP InhibitorKorea, Republic of
-
AbbVie (prior sponsor, Abbott)CompletedBrain Diseases | Central Nervous System Diseases | Neoplasm Metastasis | Brain Neoplasms | Nervous System NeoplasmsUnited States, Canada, Puerto Rico
-
National Cancer Institute (NCI)Active, not recruitingSmall Cell Lung Cancer | Extra-Pulmonary Small Cell CarcinomasUnited States
-
Jeil Pharmaceutical Co., Ltd.Completed
-
Sohag UniversityRecruiting
-
Abramson Cancer Center at Penn MedicineRecruiting
-
New Mexico Cancer Care AllianceActive, not recruitingPeritoneal Neoplasms | Ovarian Cancer | Fallopian Tube CancerUnited States
-
Atridia Pty Ltd.Completed
-
University Medical Center GroningenAbbVie; Dutch Cancer SocietyWithdrawn
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingOvarian CarcinomaUnited States
-
University of Texas Southwestern Medical CenterCompletedBreast Cancer | Ovarian CancerUnited States
-
Jonsson Comprehensive Cancer CenterPfizer; Translational Research in OncologyRecruitingRecurrent Extensive Stage Small Cell Lung Carcinoma | Refractory Extensive Stage Small Cell Lung CarcinomaUnited States
-
Inotek Pharmaceuticals CorporationCompletedAcute Myocardial InfarctionUnited States, Israel
-
Oslo University HospitalChromaDex, Inc.Completed
-
National Cancer Institute (NCI)Terminated
-
Duke UniversityAstraZenecaCompletedTriple Negative Breast CancerUnited States
-
Merck Sharp & Dohme LLCTerminatedNeoplasms | Solid Tumors
-
Seoul National University HospitalSamsung Medical Center; Takeda; Asan Medical Center; Yonsei UniversityNot yet recruitingOvarian Cancer | Epithelial Ovarian Cancer | Ovarian Cancer Stage IV | Ovarian Cancer Stage III
-
ARCAGY/ GINECO GROUPTesaro, Inc.Completed
-
Yonsei UniversityCanariaBio Inc.RecruitingPARP Inhibitor Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients Not Candidate for Platinum RetreatmentKorea, Republic of
-
The University of Hong KongRecruitingRecurrent Glioblastoma | Recurrent Glioma | Poly ADP Ribose Polymerase (PARP) Inhibitor | PTEN Gene Inactivation | IDH MutationHong Kong
-
AstraZenecaActive, not recruitingRelapsed Ovarian Cancer | Following Complete or Partial Response to Platinum Based Chemotherapy | Platinum SensitiveChina, Malaysia
-
Hospital of MacerataNot yet recruiting